Cargando…

Tetherin antagonism by HIV-1 and its SIV precursors

Detalles Bibliográficos
Autor principal:	Kirchhoff, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236893/ http://dx.doi.org/10.1186/1742-4690-8-S2-O8

Ejemplares similares

HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
por: Goffinet, Christine, et al.
Publicado: (2009)

Tetherin restricts direct cell-cell viral transfer and transmission of HIV-1
por: Kuhl, BD, et al.
Publicado: (2010)

Innate sensing of retroviral assembly by tetherin
por: Neil, Stuart
Publicado: (2013)

HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef
por: Sauter, Daniel, et al.
Publicado: (2011)

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
por: Zhang, Fengwen, et al.
Publicado: (2011)

Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques
por: Tavakoli-Tameh, Aidin, et al.
Publicado: (2020)

Nef interferes with development of thymic T cell precursors: differential mechanisms in HIV and SIV
por: Meuwissen, PJ, et al.
Publicado: (2011)

Feline tetherin (BST-2) restricts feline immunodeficiency virus release but not spreading infection
por: Dietrich, Isabelle, et al.
Publicado: (2011)

In vivo-expression profile and regulation of the antiviral restriction factor CD317/tetherin in humans
por: Erikson, Elina, et al.
Publicado: (2011)

Lv4, an activity that restricts nuclear entry of SIV(MAC)/SIV(SM) in human blood cells
por: Pizzato, Massimo, et al.
Publicado: (2013)

Why are pathogenic SIV and HIV infections characterized by high level immune activation when other chronic virus infection are not? Lessons from nonpathogenic SIV infection in natural host species
por: Staprans, Silvija, et al.
Publicado: (2006)

A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
por: Jensen, K, et al.
Publicado: (2012)

Acute infection by SIV: massive immunological damage
por: Roederer, Mario
Publicado: (2006)

Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
por: Jia, Bin, et al.
Publicado: (2009)

Antagonizing the effects of Bst-2/tetherin: multiple ways to accomplish a common goal
por: Strebel, Klaus
Publicado: (2009)

Nef-mediated TCR-CD3 and MHC-I down-modulation prevents CD4+ T cell depletion in natural SIV infection
por: Schindler, Michael, et al.
Publicado: (2006)

Analysis of Determinants in Filovirus Glycoproteins Required for Tetherin Antagonism
por: Gnirß, Kerstin, et al.
Publicado: (2014)

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism
por: Vande Burgt, Nathan H., et al.
Publicado: (2015)

OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
por: Kannanganat, S, et al.
Publicado: (2009)

Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism
por: Arias, Juan F., et al.
Publicado: (2011)

Understanding the benign nature of natural SIV infection: Implications for AIDS pathogenesis
por: Silvestri, Guido
Publicado: (2006)

Tetherin Restricts Herpes Simplex Virus 1 and Is Antagonized by Glycoprotein M
por: Blondeau, Caroline, et al.
Publicado: (2013)

Antagonism to human BST-2/tetherin by Sendai virus glycoproteins
por: Bampi, Carole, et al.
Publicado: (2013)

The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism
por: Kuhl, Björn D., et al.
Publicado: (2011)

Virus-specific cellular immune correlates of survival in vaccinated monkeys after SIV challenge
por: Letvin, Norman
Publicado: (2006)

Early pro-inflammatory host response to recombinant HSV-SIV vaccination in sooty mangabeys
por: Rout, N, et al.
Publicado: (2012)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance
por: Kmiec, Dorota, et al.
Publicado: (2016)

Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)

Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination
por: Smith, AJ, et al.
Publicado: (2012)

Intra-dermal immunisation with SIV gag-based vaccines alone inhibits acquisition of SIVmac251
por: Almond, N, et al.
Publicado: (2012)

Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys
por: Sun, C, et al.
Publicado: (2012)

Occult replication of a conditionally-live attenuated SIV profoundly upregulates T effector memory cell frequency
por: Manoussaka, Maria, et al.
Publicado: (2011)

Tetherin/BST-2 Antagonism by Nef Depends on a Direct Physical Interaction between Nef and Tetherin, and on Clathrin-mediated Endocytosis
por: Serra-Moreno, Ruth, et al.
Publicado: (2013)

Perturbations in the CD4(+)CD25(+ )regulatory T cell population of the GALT during acute SIV infection
por: Chase, Amanda J, et al.
Publicado: (2006)

Anti-retroviral innate immune responses in multiple lymphoid tissues elicited by protective live attenuated SIV vaccination
por: Mattiuzzo, Giada, et al.
Publicado: (2011)

SIVΔnef vaccination mobilizes systemic and mucosal natural killer cells in Mamu A*01+ macaques
por: Reeves, R, et al.
Publicado: (2012)

OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
por: Strbo, N, et al.
Publicado: (2009)

Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment
por: Dubé, Mathieu, et al.
Publicado: (2010)

Epitope specificity appears to be an important determinant of in vivo killing ability of simian immunodeficiency virus (SIV)-specific CD8+ T Cells
por: Pozzi, L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ufs0p22pk957i1bf48rq29g1mr